We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+2.58%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.19B
AUM Growth
+$36.9M
(+3.2%)
Cap. Flow
+$23.2M
Cap. Flow
% of AUM
1.95%
Top 10 Holdings %
Top 10 Hldgs %
24.45%
Holding
247
New
25
Increased
97
Reduced
83
Closed
19
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$7.85M |
| 2 |
Cardinal Health
CAH
|
+$7.3M |
| 3 |
Salesforce
CRM
|
+$6.7M |
| 4 |
Medtronic
MDT
|
+$6.22M |
| 5 |
Bank OZK
OZK
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$6.83M |
| 2 |
United Parcel Service
UPS
|
+$5.99M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$4.81M |
| 4 |
GE Aerospace
GE
|
+$4.58M |
| 5 |
Microsoft
MSFT
|
+$4.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.6% |
| 2 | Technology | 15.03% |
| 3 | Healthcare | 13.46% |
| 4 | Miscellaneous | 12.49% |
| 5 | Energy | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BSJH
76
DELISTED
Guggenheim BulletShares 2017 High Yield Corporate Bond ETF
BSJH
| $3.56M | 0.3% |
134,830
+41,875
| +45% | +$1.1M |
2013 Q4
5 quarters
|
|
77
Home Depot
HD
$305B
| $3.39M | 0.29% |
29,836
+9,040
| +43% | +$997K |
2013 Q2
7 quarters
|
|
78
Bristol-Myers Squibb
BMY
$124B
| $3.25M | 0.27% |
50,426
+4,745
| +10% | +$297K |
2013 Q2
7 quarters
|
|
79
AbbVie
ABBV
$505B
| $3.21M | 0.27% |
54,821
-4,782
| -8% | -$289K |
2013 Q2
7 quarters
|
|
80
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $2.94M | 0.25% |
27,463
+1,731
| +7% | +$185K |
2014 Q4
1 quarter
|
|
81
Target
TGT
$71.4B
| $2.83M | 0.24% |
34,509
-9,840
| -22% | -$760K |
2013 Q2
7 quarters
|
|
82
AT&T
T
$161B
| $2.68M | 0.23% |
108,824
+13,440
| +14% | +$342K |
2013 Q2
7 quarters
|
|
83
McKesson
MCK
$116B
| $2.42M | 0.2% |
10,711
+108
| +1% | +$24K |
2013 Q2
7 quarters
|
|
84
JPMorgan Chase
JPM
$887B
| $2.42M | 0.2% |
39,879
-254
| -0.6% | -$15K |
2013 Q2
7 quarters
|
|
85
ConocoPhillips
COP
$171B
| $2.33M | 0.2% |
37,413
-717
| -2% | -$46.4K |
2013 Q2
7 quarters
|
|
86
DELISTED
Du Pont De Nemours E I
DD
| $2.22M | 0.19% |
32,657
+4,107
| +14% | +$293K |
2013 Q2
7 quarters
|
|
87
iShares Core S&P Small-Cap ETF
IJR
$103B
| $2.13M | 0.18% |
36,050
-3,250
| -8% | -$186K |
2013 Q2
7 quarters
|
|
88
Alerian MLP ETF
AMLP
$12.5B
| $2.05M | 0.17% |
24,689
-64
| -0.3% | -$5.41K |
2013 Q2
7 quarters
|
|
89
General Mills
GIS
$17.7B
| $1.93M | 0.16% |
34,057
-920
| -3% | -$49.1K |
2013 Q2
7 quarters
|
|
90
Travelers Companies
TRV
$79.3B
| $1.89M | 0.16% |
17,503
-1,598
| -8% | -$171K |
2013 Q2
7 quarters
|
|
91
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.82M | 0.15% |
19,447
-1,525
| -7% | -$130K |
2013 Q2
7 quarters
|
|
92
Illinois Tool Works
ITW
$77.3B
| $1.78M | 0.15% |
18,319
-280
| -2% | -$27K |
2013 Q2
7 quarters
|
|
93
Vanguard High Dividend Yield ETF
VYM
$81.3B
| $1.77M | 0.15% |
25,896
-1,814
| -7% | -$125K |
2013 Q2
7 quarters
|
|
94
Novartis
NVS
$287B
| $1.7M | 0.14% |
19,245
-560
| -3% | -$49.7K |
2013 Q2
7 quarters
|
|
95
Berkshire Hathaway Class B
BRK.B
$1.13T
| $1.64M | 0.14% |
11,384
+1,328
| +13% | +$195K |
2013 Q2
7 quarters
|
|
96
RTX Corp
RTX
$250B
| $1.58M | 0.13% |
21,464
-359
| -2% | -$26.8K |
2013 Q2
7 quarters
|
|
97
iShares Core S&P 500 ETF
IVV
$887B
| $1.49M | 0.13% |
7,181
-28
| -0.4% | -$5.82K |
2014 Q3
2 quarters
|
|
98
Kimberly-Clark
KMB
$34.5B
| $1.38M | 0.12% |
12,867
+1,205
| +10% | +$133K |
2013 Q2
7 quarters
|
|
99
Phillips 66
PSX
$116B
| $1.29M | 0.11% |
16,420
-807
| -5% | -$59.2K |
2013 Q2
7 quarters
|
|
100
Dominion Energy
D
$55.2B
| $1.28M | 0.11% |
17,997
+206
| +1% | +$15.3K |
2013 Q2
7 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Cambridge Trust held 247 positions worth $1.19B, up 3.2% from $1.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cambridge Trust's Q1 2015 filing shows 25 new, 97 increased, 83 reduced and 19 closed positions. Its largest new stake was Cardinal Health: 84,772 shares worth $7.65M. The largest sale was Verizon, an estimated $6.83M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Cambridge Trust's largest Q1 2015 buy was Cardinal Health: 84,772 shares worth $7.65M.
- Cambridge Trust added most to Visa in Q1 2015, an estimated $7.85M increase.
- Cambridge Trust's biggest Q1 2015 reduction was Verizon, cutting an estimated $6.83M.
- Cambridge Trust fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $4.81M.
- Cambridge Trust's ten largest holdings make up 24% of its $1.19B portfolio in Q1 2015.
- Cambridge Trust opened 25 new positions and closed 19 in Q1 2015.
- Cambridge Trust's portfolio value rose 3.2% quarter-over-quarter to $1.19B.
Based on Cambridge Trust's 13F filing for Q1 2015, filed 1 Jun 2015.